دراسة فعالية الفينوباربيتال في علاج فرط بيلروبين الدم عند الولدان
Other Title(s)
The efficiency of phenobarbital in treating hyperbilirubinemia in neonates
Author
Source
Issue
Vol. 38, Issue 1 (31 Mar. 2022), pp.145-150, 6 p.
Publisher
Publication Date
2022-03-31
Country of Publication
Syria
No. of Pages
6
Main Subjects
Abstract EN
Background and Aim: Hyperbilirubinemia in neonates is a common condition, that faced the pediatrician in his practice, and many cases of them were put on phenobarbital as a management.
This study aim to: assessment of the efficiency of phenobarbital in treating hyperbilirubinemia in neonates.
Materials and Methods: it was an analysis study of 60 neonates (with no risk factors) who had hyperbilirubinemia and asked a medical advice in children hospital (neonatal emergency department).
Results: our total group contained 60 patients, 20 of them were put on phenobarbital, 16 cases were improved (80%), and the rest of the group 40 patients did not receive any medications, 35 of them were improved (87.5%).
Conclusion: it is better to avoid giving phenobarbital to neonates with hyperbilirubinemia, who are full term and with no risk factors
American Psychological Association (APA)
كندة إسماعيل. 2022. دراسة فعالية الفينوباربيتال في علاج فرط بيلروبين الدم عند الولدان. مجلة جامعة دمشق للعلوم الطبية،مج. 38، ع. 1، ص ص. 145-150.
https://search.emarefa.net/detail/BIM-1431685
Modern Language Association (MLA)
كندة إسماعيل. دراسة فعالية الفينوباربيتال في علاج فرط بيلروبين الدم عند الولدان. مجلة جامعة دمشق للعلوم الطبية مج. 38، ع. 1 (2022)، ص ص. 145-150.
https://search.emarefa.net/detail/BIM-1431685
American Medical Association (AMA)
كندة إسماعيل. دراسة فعالية الفينوباربيتال في علاج فرط بيلروبين الدم عند الولدان. مجلة جامعة دمشق للعلوم الطبية. 2022. مج. 38، ع. 1، ص ص. 145-150.
https://search.emarefa.net/detail/BIM-1431685
Data Type
Journal Articles
Language
Arabic
Notes
يتضمن مراجع ببليوجرافية : ص. 150
Record ID
BIM-1431685